These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34089357)

  • 61. SARS-CoV-2-specific virulence factors in COVID-19.
    Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
    J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of acute gout: a systematic review.
    Khanna PP; Gladue HS; Singh MK; FitzGerald JD; Bae S; Prakash S; Kaldas M; Gogia M; Berrocal V; Townsend W; Terkeltaub R; Khanna D
    Semin Arthritis Rheum; 2014 Aug; 44(1):31-8. PubMed ID: 24650777
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.
    Niles MA; Gogesch P; Kronhart S; Ortega Iannazzo S; Kochs G; Waibler Z; Anzaghe M
    Front Immunol; 2021; 12():647824. PubMed ID: 34122407
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Familial Mediterranean Fever and COVID-19: Friends or Foes?
    Stella A; Lamkanfi M; Portincasa P
    Front Immunol; 2020; 11():574593. PubMed ID: 33072117
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Update on colchicine and its mechanism of action.
    Molad Y
    Curr Rheumatol Rep; 2002 Jun; 4(3):252-6. PubMed ID: 12010611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A scoping review of the pathophysiology of COVID-19.
    Marik PE; Iglesias J; Varon J; Kory P
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048026. PubMed ID: 34569339
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Colchicine - new horizons for an ancient drug. Review based on the highest hierarchy of evidence.
    Schattner A
    Eur J Intern Med; 2022 Feb; 96():34-41. PubMed ID: 34657777
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Does reduced interferon immunity lead to more serious COVID-10 symptoms?].
    Gudbjartsson D
    Laeknabladid; 2020 Nov; 106(11):501. PubMed ID: 33107839
    [No Abstract]   [Full Text] [Related]  

  • 70. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
    Zhang FS; He QZ; Qin CH; Little PJ; Weng JP; Xu SW
    Acta Pharmacol Sin; 2022 Sep; 43(9):2173-2190. PubMed ID: 35046517
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Colchicine in COVID-19: an Old Drug, New Use.
    Schlesinger N; Firestein BL; Brunetti L
    Curr Pharmacol Rep; 2020; 6(4):137-145. PubMed ID: 32837853
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gout Storm.
    Martins D; Tonon CR; Pacca RL; Matchil NL; Junior LAJ; Queiroz DS; Pereira FWL; Silva AM; Padovese V; Padovani de Toledo Moraes M; Luiz da Silva D; Cardoso Nóbrega V; Curcelli EC; Okoshi MP
    Am J Case Rep; 2021 Sep; 22():e932683. PubMed ID: 34855717
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial.
    Perricone C; Scarsi M; Brucato A; Pisano P; Pigatto E; Becattini C; Cingolani A; Tiso F; Prota R; Tomasoni LR; Cutolo M; Tardella M; Rozza D; Zerbino C; Andreoni M; Poletti V; Bartoloni E; Gerli R;
    Eur J Intern Med; 2023 Jan; 107():30-36. PubMed ID: 36396522
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Melatonin multifaceted pharmacological actions on melatonin receptors converging to abrogate COVID-19.
    Reynolds JL; Dubocovich ML
    J Pineal Res; 2021 Aug; 71(1):e12732. PubMed ID: 33759236
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
    Manenti L; Maggiore U; Fiaccadori E; Meschi T; Antoni AD; Nouvenne A; Ticinesi A; Cerundolo N; Prati B; Delsante M; Gandoflini I; Donghi L; Gentile M; Farina MT; Oliva V; Zambrano C; Regolisti G; Palmisano A; Caminiti C; Cocchi E; Ferrari C; Riella LV; Cravedi P; Peruzzi L
    PLoS One; 2021; 16(3):e0248276. PubMed ID: 33760858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19.
    Salah HM; Mehta JL
    Am J Cardiol; 2021 Apr; 145():170-172. PubMed ID: 33617817
    [No Abstract]   [Full Text] [Related]  

  • 78. Colchicine and the heart.
    Imazio M; Nidorf M
    Eur Heart J; 2021 Jul; 42(28):2745-2760. PubMed ID: 33961006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of colchicine on mortality and morbidity in COVID-19: a systematic review.
    Sanghavi D; Bansal P; Kaur IP; Mughal MS; Keshavamurthy C; Cusick A; Schram J; Yarrarapu SNS; Giri AR; Kaur N; Moreno Franco P; Abril A; Aslam F
    Ann Med; 2022 Dec; 54(1):775-789. PubMed ID: 35258357
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Colchicine for the treatment of cardiovascular diseases: old drug, new targets.
    Andreis A; Imazio M; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):1-8. PubMed ID: 32858634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.